Breast Cancer
Expert Talks Immunotherapy for TNBC Treatment
BY JESSICA HERGERT
FDA Approves Sactizumab Govitecan for TNBC: What Nurses Need to Know
BY BRIELLE BENYON
ICYMI: A Rundown of the 5 Latest FDA Approvals
BY BRIELLE BENYON
Patient Education for Oral Therapies Is Crucial
BY PATRICIA JAKEL, MN, RN, AOCN
FDA Approves Sacituzumab Govitecan for Triple-Negative Breast Cancer
BY JASON M. BRODERICK
FDA Approves Tucatinib to Treat HER2+ Breast Cancer
BY JASON M. BRODERICK
COVID-19 Breast Cancer Recommendations Stratify Patients by Risk
BY BRIELLE BENYON
Oncology Nursing News: Top Stories of March 2020
BY JESSICA SKARZYNSKI
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.